The benefits, costs and feasibility of a low incidence COVID-19 strategy

Export/share

Czypionka, ThomasORCID: https://orcid.org/0000-0002-3381-1075; Iftekhar, Emil N.; Prainsack, Barbara; Priesemann, Viola; Bauer, Simon; Calero Valdez, André; Cuschieri, Sarah; Glaab, Enrico; Grill, Eva; Krutzinna, Jenny; Lionis, Christos; Machado, Helena; Martins, Carlos; Pavlakis, George N.; Perc, Matjaž; Petelos, Elena; Pickersgill, Martyn; Skupin, Alexander; Schernhammer, Eva; Szczurek, Ewa; Tsiodras, Sotirios; Willeit, Peter and Wilmes, Paul (2022) The benefits, costs and feasibility of a low incidence COVID-19 strategy. The Lancet Regional Health - Europe, 13, article 100294. https://doi.org/10.1016/j.lanepe.2021.100294

[thumbnail of czypionka-et-al-2022-benefits-feasibility-covid-19-strategy.pdf]

Preview

Text
czypionka-et-al-2022-benefits-feasibility-covid-19-strategy.pdf - Published Version
Available under License Creative Commons Attribution.
Download (456kB) | Preview

Official URL: https://doi.org/10.1016/j.lanepe.2021.100294

Item Type:	Article in Academic Journal
Research Units:	Health Economics and Health Policy
Date Deposited:	11 Jan 2022 07:56
Last Modified:	19 Sep 2024 08:54
DOI:	10.1016/j.lanepe.2021.100294
ISSN:	26667762
URI:	https://irihs.ihs.ac.at/id/eprint/6023

Actions (login required)

: View Item

Altmetric

CORE (COnnecting REpositories)